Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 11 studies | 30% ± 14% | |
| kidney | 8 studies | 22% ± 4% | |
| peripheral blood | 7 studies | 20% ± 3% | |
| intestine | 6 studies | 25% ± 12% | |
| brain | 6 studies | 34% ± 20% | |
| liver | 5 studies | 26% ± 17% | |
| pancreas | 3 studies | 42% ± 1% | |
| eye | 3 studies | 24% ± 7% | |
| thymus | 3 studies | 37% ± 14% | |
| lymph node | 3 studies | 28% ± 10% | |
| breast | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 1403.03 | 2642 / 2642 | 100% | 41.00 | 705 / 705 |
| esophagus | 100% | 1292.16 | 1445 / 1445 | 100% | 40.22 | 183 / 183 |
| liver | 100% | 793.24 | 226 / 226 | 100% | 34.64 | 406 / 406 |
| ovary | 100% | 1194.72 | 180 / 180 | 100% | 78.29 | 430 / 430 |
| stomach | 100% | 1034.52 | 359 / 359 | 100% | 41.61 | 286 / 286 |
| uterus | 100% | 1155.71 | 170 / 170 | 100% | 64.37 | 459 / 459 |
| thymus | 100% | 1698.71 | 653 / 653 | 100% | 60.85 | 604 / 605 |
| intestine | 100% | 1296.20 | 966 / 966 | 100% | 43.64 | 526 / 527 |
| prostate | 100% | 1564.83 | 245 / 245 | 100% | 56.14 | 501 / 502 |
| kidney | 100% | 1543.79 | 89 / 89 | 100% | 39.11 | 899 / 901 |
| breast | 100% | 1256.39 | 459 / 459 | 100% | 55.50 | 1114 / 1118 |
| bladder | 100% | 1253.57 | 21 / 21 | 100% | 51.79 | 502 / 504 |
| lung | 99% | 1064.47 | 575 / 578 | 100% | 55.79 | 1155 / 1155 |
| adrenal gland | 100% | 2003.10 | 258 / 258 | 99% | 38.80 | 228 / 230 |
| skin | 100% | 1341.16 | 1808 / 1809 | 99% | 30.62 | 467 / 472 |
| pancreas | 99% | 674.31 | 326 / 328 | 99% | 38.88 | 177 / 178 |
| adipose | 100% | 1116.66 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 43.42 | 29 / 29 |
| spleen | 100% | 981.13 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 42.74 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 20.56 | 1 / 1 |
| blood vessel | 100% | 1315.95 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 825.68 | 801 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 783.23 | 844 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 22.27 | 76 / 80 |
| peripheral blood | 83% | 719.41 | 768 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0016197 | Biological process | endosomal transport |
| GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
| GO_0005802 | Cellular component | trans-Golgi network |
| GO_0048188 | Cellular component | Set1C/COMPASS complex |
| GO_0044665 | Cellular component | MLL1/2 complex |
| GO_0035097 | Cellular component | histone methyltransferase complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0071339 | Cellular component | MLL1 complex |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0044666 | Cellular component | MLL3/4 complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | DPY30 |
| Protein name | Protein dpy-30 homolog (Dpy-30-like protein) (Dpy-30L) |
| Synonyms | |
| Description | FUNCTION: As part of the MLL1/MLL complex, involved in the methylation of histone H3 at 'Lys-4', particularly trimethylation. Histone H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. May play some role in histone H3 acetylation. In a teratocarcinoma cell, plays a crucial role in retinoic acid-induced differentiation along the neural lineage, regulating gene induction and H3 'Lys-4' methylation at key developmental loci. May also play an indirect or direct role in endosomal transport. . |
| Accessions | Q9C005 ENST00000295066.3 ENST00000342166.10 |